Patient Leaflet Updated 13-Oct-2021 | Alliance Pharmaceuticals
Ranitidine 50mg/2ml Solution for Injection and Infusion
Ranitidine 50mg/2ml Solution for Injection and Infusion
ranitidine hydrochloride
The name of this medicine is Ranitidine 50mg/2ml Solution for Injection and Infusion (referred to as Ranitidine Injection throughout this leaflet).
1. What Ranitidine Injection is and what it is used for
2. What you need to know before you have Ranitidine Injection
3. How to have Ranitidine Injection
4. Possible side effects
5. How to store Ranitidine Injection
6. Contents of the pack and other information
Ranitidine Injection is a solution for injection or infusion into a vein, or injection into a muscle. It contains ranitidine as the active substance.
Ranitidine is one of a group of medicines called H2-antagonists that lowers the amount of acid in your stomach.
If you are not sure talk to your doctor or pharmacist before having Ranitidine Injection.
Talk to your doctor or pharmacist before having Ranitidine Injection:
If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before having this medicine.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines that you buy without a prescription and herbal medicines. This is because ranitidine can affect the way some other medicines work. Also some other medicines can affect the way ranitidine works.
In particular tell your doctor or pharmacist if you are taking any of the following medicines:
Midazolam may also be given before an operation. Tell your doctor you are taking ranitidine before you have an operation in case he or she wants to give you midazolam.
If you are taking erlotinib, a drug used for the treatment of certain types of cancer, talk to your doctor before you take Ranitidine Injection. Ranitidine contained in Ranitidine Injection may decrease the amount of erlotinib in your blood and your doctor may need to adjust your treatment if it is used while you are receiving erlotinib.
If you are not sure if any of the above applies to you, talk to your doctor, pharmacist or nurse before having Ranitidine Injection.
If you are pregnant, might become pregnant or breast-feeding you should not be given this medicine unless your doctor advises it is essential.
Ask your doctor, pharmacist or nurse for advice before taking any medicine, if you are pregnant or breast-feeding.
Ranitidine Injection is unlikely to affect your ability to drive or operate machinery
Ranitidine Injection contains less than 1 mmol sodium (23 mg) per 50 mg, i.e. essentially sodium-free.
Ranitidine Injection contains less than 1mmol potassium (39mg) per 50mg, i.e. essentially potassium-free
You will never be expected to give yourself this medicine. It will always be given to you by someone who is trained to do so.
Your doctor will decide the correct dose of Ranitidine Injection for you.
Adults (including the elderly) and adolescents (12 years and older): This can be given by the doctor or nurse in one of three ways:
The recommended dose for an adult (including the elderly) and adolescents (12 years and older) is 50 mg every 6 to 8 hours, as a single injection into a muscle.
Different doses may also be given to you as a slow infusion or continuous infusion, depending on what condition you are being treated for.
Children and infants (6 months to 11 years): The dose will be given by a slow injection into a vein. The maximum dose is 50mg every 6 or 8 hours. It is usually only given if your child is unable to take ranitidine by mouth.
Kidney disease: If your kidneys are not working properly your doctor may give you a lower dose.
Your doctor or nurse will give you Ranitidine Injection so it is unlikely that you will receive too much. If you think that the effect of Ranitidine Injection is too strong or too weak or you have missed a dose, talk to your doctor or nurse. If you have any further questions on the use of this product, ask your doctor or nurse.
Like all medicines, Ranitidine Injection can cause side effects, although not everybody gets them.
If any of the following happen, tell your doctor or nurse immediately as you may need urgent medical attention:
Tell your doctor at your next visit if you notice any of the following:
Rare side effects that may show up in blood tests:
If you get any side effects talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:
UK:
The Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store..
IE:
By reporting side effects you can help provide more information on the safety of this medicine.
Do not store above 25°C.
Keep ampoules in the carton to protect them from light.
Keep this medicine out of the sight and reach of children.
Ranitidine Injection should not be used after the expiry date which is stated on the ampoule and carton. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is ranitidine. One 2ml ampoule contains 50mg of ranitidine as ranitidine hydrochloride.
Other ingredients are sodium chloride, potassium dihydrogen phosphate, disodium hydrogen phosphate dihydrate and water for injections.
Ranitidine Injection is a clear, colourless liquid in amber glass ampoules.
Each carton of Ranitidine Injection contains 5 ampoules.
This leaflet was last revised in May 2020
Alliance and associated devices are registered trademarks of Alliance Pharmaceuticals Limited
© Alliance Pharmaceuticals Limited 2020
Ranitidine PIL UK ROI 008
Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB
+44 (0)1249 466 977
+44 (0)1249 466 966
http://www.alliancepharma.co.uk